drugset / Trial / NCT04300322

Pessary Versus Progesterone in Singletons

NCT04300322

RandomizedParallel-groupOpen-labelPrevention

Summary

This study compares the effectiveness of cervical pessary to vaginal progesterone for prevention of preterm birth in women with singleton pregnancies and a cervix ≤25 mm. Participants will be randomly assigned in a 1:1 ratio to receive cervical pessary or vaginal progesterone.

Timeline

Start
2020-05-01
Primary completion
2022-03-01
Completion
2022-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg

Indications